American Assn for the Study of Liver Diseases
Based in VA
🤖
AI Overview
With $1.6M in lobbying spend across 32 quarterly filings, American Assn for the Study of Liver Diseases is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2025.
$1.6M
Total Spend
8
Years Active
1
Firms Hired
5
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Health Issues
- •Medicare reimbursement rates
- •MACRA Implementation, Chronic Care Reform
- •Liver Disease Research & Funding
- •H.R.no bill #/S.3158 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
National Community Pharmacists Association
$15.4M total spend
Healthcare Distribution Alliance (Formerly - Hdma)
$13.2M total spend
American Academy of Otolaryngology-head and Neck Surgery
$8.0M total spend
Infectious Diseases Society of America
$5.1M total spend
Association for Clinical Oncology
$4.8M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.